Ledger.Open graph →
SEC Form D · filed March 26, 2020

Nurix Therapeutics, Inc

Offering
$120.2M
Sold
$120.2M
Exemption
Rule 506(b)
Industry
Other
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Robert Tjian · San Francisco, CADirectorArthur Sands · San Francisco, CAExec · DirectorLori Kunkel · Brisbane, CADirectorJulia Gregory · South San Francisco, CADirectorJeff Tong · San Francisco, CADirectorDavid Lacey · San Francisco, CADirectorChristine Ring · San Francisco, CAExecHans Van Houte · San Francisco, CAExecLeon Chen · Austin, TXDirectorArthur Sands · San Francisco, CAExec · DirectorLori Kunkel · Brisbane, CADirectorJulia Gregory · South San Francisco, CADirectorJeff Tong · San Francisco, CADirectorRobert Tjian · San Francisco, CADirectorDavid Lacey · Redwood City, CADirectorChristine Ring · San Francisco, CAExecHans Van Houte · San Francisco, CAExecLeon Chen · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗